NCT04804904View on ClinicalTrials.gov

A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

June 15, 2021

Study Completion Date

July 3, 2021

Conditions
Pharmacokinetic Study
Interventions
DRUG

TQ-B3101

TQ-B3101 oral capsule

Trial Locations (1)

200000

Zhongshan Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY